Overview of Antibody Drug Conjugates in Lung Cancer
Wade Thomas Iams, MD, provides an overview of antibody drug conjugates in the treatment of patients with lung cancer, including challenges and impact on clinical practice.
Now Viewing
EP: 1.Overview of Antibody Drug Conjugates in Lung Cancer
EP: 2.ADCs in Development for the Treatment of Lung Cancer
EP: 3.Targeting CEACAM5 in Patients with Non-Small Cell Lung Cancer
EP: 4.HER2-Directed Agents in NSCLC
EP: 5.Targeting HER3 in EGFR-Mutant NSCLC
EP: 6.Exploring TROP2 Expression in Patients with NSCLC
Related Videos
Related Content
